In Côte d'Ivoire pharmacopoeia the antifungal virtues of the bark of Terminalia mantaly are known. It bark is used to cure affections such as cutaneous candidiasis, gingivitis and diarrhoea. This work aims to compare the anticandidosic activities of the crude extract of T. mantaly and an ointment containing shea butter and the crude extract of T. mantaly. The anticandidosic activity of the crude Shea butter was also evaluated and kétoconazole was used as standards for antifungal assay.
INTRODUCTION
In the world, the infectious diseases knew higher fresh outbreak during the last decades ( 1 Dromer et al., 2013) .The diseases due to pathogenic resistant species are in great progression ( 2 Assob and Nsagha, 2014 ) and mycosis are among these pathologies ( 3 Hitchkock, 1993: 1 Dromer et al., 2013; 2 Assob and Nsagha, 2014). This fresh outbreak of mycosis comes from several factors. Among them, change in the clinical spectrum of classic pathogenic, apparition of diverse resistances in the usual antifungals and the strong progress of immunodépressive affections such as HIV-AIDS ( On the therapeutic level, the number of proposed remedies remains limited. Moreover some molecules lost their effectiveness due to resistance phenomena and change ( 7 Vanden, 1997; 8 Sanglard et al., 1998; 9 Freiman and Sasseville, 2006). To this is added the cost more and more raised of some medicine sold in the modern pharmacies. The financial difficulties of the populations direct them to the use of healing plants ( 10 Aké-Assi, 1991; 11 Cowan, 1999 Kra et al., 2015) . Kra et al., 2014) . For better appreciation of the use of T mantaly in human therapeutics, the present study was initiated to evaluate and compare the anticandidosic activities of the crude hydroethanolic extract of T. mantaly and to those of the ointment formulated from this extract.
MATERIAL AND METHODS

Plant Material
Bark of Terminalia mantaly
The Plant material was a powder obtained after crushing the dried bark pieces of T mantaly codified TEKAM 1.
Shea Butter
The Shea butter (SB) was extracted from nuts of Butyrospermum parkii (G Don) Kotschy (Sapotaceae). This species spontaneously grows in the north of Côte d'Ivoire. The SB was heated and purified by decantation.
Microorganism Studied
The tested fungus was the clinical and identified strain of C. albicans . This strain was provided by the Laboratory of Mycology of the Medical Sciences Faculty of the Felix Houphouët Boigny University (Abidjan, Côte d'Ivoire).
METHODS
Preparation of the vegetable extracts Extraction
The plant bark was cut into small pieces and carefully air-dried for 2 weeks at room temperature in the laboratory, under continuous ventilation, away from sunlight and dust. After this step, the vegetal piece was crushed to a fine powder with an electric grinder IKA-MAG. The powder obtained were codified TEKAM 1 .
The hydro-ethanolic rough extracts were prepared from TEKAM 1 . Hundred grams (100g) of bark powder was extracted by homogenization in a blender with 1 L of mixture of ethanol 70% and distilled water 30%. After six cycles of homogenization, the homogenates obtained were first wrung out in a fabric square and then filtered twice successively with absorbent cotton and once with Whatman 3 mm filter paper. The resulting filtrate was concentrated under vacuum using a Büchi rotary evaporator at 60°C ( 25 Zirihi et al., 2011) . This powder was hermetically sealed in polyethylene bags and stored away from light and moisture until the time of extraction. Dark powder obtained is the hydro-ethanolic crude extract codified TEKAM 1 -X 0
The shea butter (SB)
SB is a clear yellow product. It was used as excipient main of the ointment. It melting point is between 33 and 42 °C. Its density at 15°C is between 0,915 and 0,920.
Oitment Quality
Macroscopic Characters
The clear brown ointment obtained by the mixture of Shea and extract TEKAM 1 -X 0 codified TEPOM. It is an unctuous cream with soft consistency. The smell like of the Shea butter
Homogénéity
The ointment homogeneity was verified by applying on thin (confinement) layer a plane surface using a spatula. The regular distribution or not of the extracts in excipient was noted. It presents a very homogeneous without curds and smooth aspect to the touch.
pH Measure
The pH determined was that of a dilution to the tenth of the ointment in heater distilled water. The pH obtained is generally 5, 5.
Medium and ointment preparation
The anti-fungal tests were carried out on culture medium Sabouraud (Biomerieux / Ref: 180930; batch 401513b). The incorporation of plant extracts into the agar was made using the agar slanted double dilution method ( Bean et al., 1969) .
Anti-microbial test
Fungal germs culture on slanted agar previously prepared was made by sowing 1000 cells of C. albicans ( 28 Holt, 1975 Holt, 1975) In practice, the MFC is the extract concentration in the tube, which gave 99.99% inhibition compared to the control growth tube It also made possible to plot the curves of activity of the extracts and the graphically determination of the IC 50 values.
Formula to calculate the survival percentage:
S: Survival (%) n: Number of colony in one experimental tube N: Number of colony in the growth control tube.
RESULTS
After 48 hours of incubation at 30ºC, we observed comparatively to control tube a progressive decrease in the number of colonies gradually as the concentrations of the plant extract increased in the experimental tubes. The results were summarized in the form of curves of activity on Figure 1 and in table I containing the various values of MFC and IC 50 .
In general, all sensitivity curves showed a progressively decreasing pace with slopes that are stronger or not as strong according to the extracts. The TEPOM accentuated slope curve illustrates high anti-fungal potency. In contrast the Shea slope curve is less accentuated. It reveals low anti-fungal potency of this SB. 
DISCUSSION
The analysis of the whole results shows that C. albicans is sensitive to all substances tested namely TEKAM 1 -X 0 , SB, TEPOM and Kétoconazole according to relation dosis-dependent. However, the levels of these anti-fungal activities are variable from one substance to another.
According to the classification scale of the levels of the activities of 24 Kra et al.,(2014) , TEPOM, TEKAM 1 -X 0 and Kétoconazole anti-fungal activities are classified as very high levels of activity. The anticandidosic activity of SB is very low. Among these substances, TEPOM is most active on C. albicans for having generated the lowest values of MFC (1.874µg/mL) and IC 50 (0.047µg/mL). In contrast, of TEPOM, SB was the less active. It generated a fungistatic activity because none tested concentration completely inhibited the growth of C albicans. On picture 1, its activity curve slope is very weak. The activities of TEKAM 1 -X 0 (MFC=97.5µg/mL and IC 50 = 1.14µg/mL) and Kétoconazole (MFC = 390µg/mL and IC 50 = 18.455µg/mL) range between these two extremes.
On the basis of CMF and IC 50 values, the comparison reveals that TEKAM 1 -X 0 is 4 times more active than Kétoconazole and 366.53 times more active than SB. Moreover, TEPOM is 52.02 times more active than TEKAM 1 -X 0 , 208.64times more active than Kétoconazole and 8890.42 times more active than SB. So, incorporation of TEKAM 1 -X 0 extract in the Shea butter has generated a strong increase in the antifungal activity of this crude extract. This activity was multiplied by 52.02. The SB has noticeably maximized anticandidosic activity of TEKAM 1 -X 0 . This TEPOM can be a cure against skin mycosis. A similar product has This codified cream DAEL exhibited an excellent antifungal activity against C. albicans (MFC =3μg/mL) and T mentagrophytes (MFC = 2.4μg/mL). This DAEL cream was also used to cure diverse dermatosis such as the cropping trichophytic moths, the croppings microsporic moths, the intertrigo interdigito-plantar, the dermatophytie of the skin glabrous, the pityriasis versicolor. However, the comparison of the anticandidosic activities of TEPOM with that of DAEL antifungal cream (MFC=3µg/mL) reveals that TEPOM is 1.6 times more active than DAEL cream.
On the other hand, the qualities of the obtained ointment are similar to those obtained by 40 Rokia et al.,(2006) by its consistence, its pH (5.5) and its perfect homogeneity. However, the very strong anticandidosic activity of TEKAM 1 -X 0 has already been reported by Kra et al., (2014 and 2015) and 21 Yayé et al., (2012) who worked in similar conditions with T mantaly barks. However the comparison of extract's performances reveals that TEKAM 1 -X 0 from the present study is respectively 2 times and 21.92 times more active than the extracts prepared by these authors.
The differences of performances of these extracts could be explained by the fact that we did not collect the barks in the same area, and we did not test the extracts on the same C. albicans strain. And each fungal strain has its own sensitivity to anti-fungal drugs.
Works of 41 Baba-moussa et al. (1999) also showed that extracts from Terminalia avicennioides produced a strong antifungal activity against C albicans. But the comparison reveals that TEKAM 1 -X 0 (MFC = 97.5 μ G / ml) is 2.54 to 41 times more active than the extracts obtained by these authors. TEKAM 1 -X 0 is also 31,2 times more active than MISCA-X 1.1 (CMF=3.125 mg/mL) prepared from Mitracarpus villosus by 31 Kporou et al., (2009) .On the other hand TEKAM 1 -X 0 is 8 to 128 times more active than methanolic and ethanolic extracts of the leaves and the fruits of Rubus sanguineus tested by 42 Zeidan et al (2013) on C albicans. In addition, the dichloromethane extracts of Olea cuspidate and Olea glandulifera are 256.41 to 512.82 times less active than TEKAM 1 -X 0 because they produced antifungal activities with values going from 25 mg/ml to 50 Mg / mL on C albicans ( 43 Majgaine and Verma, 2013) . TEKAM 1 -X 0 is respectively 16 times and 69 times less active than the hydroalcoholic extracts T 3 -X 12 of Terminalia catappa tested by 44 Ackah et al.,(2008) on C. albicans .
Concerning SB, its anti-fungal activity is certainly due to the fact that it contains 3 to 17 % of insaponifiables which are the karitenes A, B, C and D, the β-amyrine, basseol, the butyrospermol, the parkeol, the luseol; Karistérols A and B and vitamins A and D which give her bacteriostatic antioxidant and fungistatic properties. The results of the present study confirm the very high antimicrobial potency extracts from plants in the Terminalia genus. Moreover results of many previous studies are in agreements with this study concerning their strong antimicrobial activities.
CONCLUSION
The present study focuses on the anti-infectious potency of Terminalia mantaly. The results of these experiences show that sensitivity of C. albicans is dose-response relationship. The extract effectiveness is more important when it is incorporated in ointment than used alone. TEPOM activity being 52 higher times than isolated crude extract, then SB noticeably increased anticandidosic extract activity. Furthermore TEPOM being much more active than the kétoconazole, this ointment can be a cure against skin mycosis. Finally from the present study it appears that using Terminalia mantaly as antimicrobial in rural area is justified.
